Dr. Philippa Pavia, head of medical strategy and board-certified veterinary surgeon at Bond Vet, outlines the modern elements of Bond Vet—a network of veterinary clinics specializing in design, technology, service, and culture—and how it provides both comfort for pet owners, pets, and staff alike, plus practical function.
Edward M. Schaeffer, MD, PhD, discusses the update process for the National Comprehensive Cancer Network’s guidelines for prostate cancer as well as how he uses the guidelines in his own practice.
This year, the South Beach Symposium Dermatology Conference celebrated its 20th anniversary. Dr. Christopher Bunick, a member of the Editorial Advisory Board of Dermatology Times, offers his takeaways on what made this conference so great, including cadaver workshops and the latest in genomics. Here’s what he had to say.
Dr. Marina Sirota discusses the new March of Dimes Prematurity Research Center at UC San Francisco (UCSF), which opened its doors in June of this year. The Center is part of the organization’s work in preterm birth rate reduction and will focus on prematurity data sharing, computational drug discovery and electronic medical record research.
CancerNetwork’s Audrey Sternberg spoke with Kirsten West, a naturopathic doctor who specializes in integrative oncology and recently joined the Riordan Clinic based in Wichita, Kansas. Dr. West has a Fellowship with the Oncology Association of Naturopathic Physicians and holds a Metabolic Approach to Cancer certificate from the Metabolic Terrain Institute of Health. In the interview, West dives into the field of integrative oncology by explaining its importance to the overall cancer care paradigm. She details recent advances in the field and spotlights how she and her colleagues play an important role in the multidisciplinary oncology team.
Jennifer Davidson, DO, discusses the recent FDA approval of ustekinumab (STELARA) to treat pediatric patients with active psoriatic arthritis with a focus on advancing care in psoriatic disease and new strategies to increase diversity in rheumatology.
Providers from Northwestern University’s EDGe BRCA+ Men’s Clinic discuss the program and how it provides coordinated multidisciplinary care for men age 40 and older with mutations in the BRCA1 or BRCA2 gene.
The dental industry is shifting from its traditional solo practice model to a more focused, group practice approach. This is leading to the rise of new approaches to what a dental practice can look like, and in the case of growing dental practice group Tend, this means sleek spaces designed to appeal to the Instagram generation. In this interview Dental Products Report Editorial Director Noah Levine speaks with Tend’s Chief Dental Officer Chris Salierno, DDS about what makes Tend’s patient experience stand out in the dental industry.
Advantage Dental+ has incorporated “teledentistry” in its practices, allowing patients to have more flexibility in a variety of services. Sharity Ludwig, EPDH, MS, is Director of Alternative Care Models at Advantage Dental+ and has expanded on some of the benefits that telehealth/teledentistry can offer both patient and practitioner. Teledentistry can serve patients in a variety of ways, including assisting patients who may otherwise be unable to access quality dental care because of location or working hours.
The University of Arkansas for Medical Sciences Myeloma Center became the first institution in the state to offer CAR T-cell therapy for patients with multiple myeloma. Frits van Rhee, MD, PhD, joins to discuss.
Sean Pittock, MD, of Mayo Clinic, dives into the technical capabilities the MS Center, and more specifically, the neuroimmunology laboratory, have to treat patients with multiple sclerosis and other neuroimmune disorders.
Alex Capano DNP, CRNP and Samantha Timmermann discuss introducing CBD in pharmacy practice, including how to ensure patients are discussing it, what are the questions pharmacists should prepare for, and what pharmacists need to learn before introducing it.
Heidi D. Finnes, PharmD, BCOP, FHOPA, president-elect of Hematology/Oncology Pharmacy Association (HOPA); senior manager of pharmacy cancer research at the Mayo Clinic Cancer Center; assistant professor of pharmacy in the Mayo Clinic College of Medicine; and director of the Mayo Clinic Cancer Center Pharmacy Shared Resource, discusses the value of in-person networking and educational events at oncology pharmacy conferences so that health care professionals can grow their professional community and their practice in the field.
In an interview with HCPLive during the Society for Dermatology Physician’s Associates (SDPA) 2022 Annual Meeting this June, Savanna Perry, PA-C, creator of The PA Platform and a physician’s assistant at Evans Dermatology, discussed her meeting session on building social presence as a healthcare professional. Perry first become interested in building an online audience when she took to blogging early into her career as a PA. Eventually her consultation business The PA Platform took off, and Perry expanded her marketing and education efforts to social media. She learned how to incorporate her profession into content that’s catered to people interested in pursuing a career in her field. Perry spoke with us on The PA Platform, her goal across social media, the services she provides aspiring PAs, the importance of combating dermatology misinformation, and advice for colleagues looking to launch an online presence.
Chris Labaki, MD, Research Associate in Medicine at Dana-Farber Cancer Institute, a recent study published discussing cancer clinical trials and the rising accrual rates after COVID-19. In the interview, Labaki discussed the results observed between the 2 cohorts, what clinicians have learned from this pandemic, and where he hopes to see this research advance in the future.
